Patients more likely to survive in-hospital cardiac arrest today, study finds

November 15, 2012 by Barbara Bronson Gray, Healthday Reporter in Cardiology

Patients more likely to survive in-hospital cardiac arrest today: study

Researchers say clear guidelines have helped.

(HealthDay)—A new study finds that survival after in-hospital cardiac arrest improved substantially from 2000 to 2009 in U.S. medical centers, probably because established guidelines were followed.

On average, people having a —when the heart stops beating—in a hospital have about a 22 percent chance of surviving at least long enough to go home. Ten years ago, they had less than a 14 percent chance of surviving until discharge, the researchers noted.

Also, the rate of neurologic disability among survivors, including motor weakness or difficulty talking, has decreased. Such problems are often associated with insufficient oxygen reaching the brain during the cardiac arrest and efforts.

"We found that survival improved among adult for two reasons: People are doing a better job of resuscitation, and they're also getting better at providing care for the patient after resuscitation," said Dr. Saket Girotra, of the division of at the University of Iowa Hospitals and Clinics, in Iowa City.

Whether or not people will survive cardiac arrest—when their heart stops beating—depends on a wide variety of factors. Some are related to the individual, such as their age and condition. Other issues are more hospital-related, including: How soon was the patient found? Who arrived at the scene and how soon was cardiopulmonary resuscitation () started? Was it a weekend? And, for survivors, did interrupted oxygen to the brain cause , such as motor weakness or difficulty talking?

The American Heart Association, which funded the study, has developed guidelines for hospitals in an effort to improve the quality of care associated with in-hospital cardiac arrest. Called "Get with the Guidelines - Resuscitation," they offer clear benchmarks to use in training staff to respond to cardiac crises. Experts say application of the guidelines may have improved survival numbers in hospitals.

"This study shows that when you follow quality and you benchmark people you can improve performance," said Dr. Ralph Sacco, a past president of the and chairman of neurology at the University of Miami Miller School of Medicine, in Florida.

Data for the research was taken from a national quality-improvement registry that includes all hospitalized patients with a confirmed cardiac arrest who have received CPR in participating hospitals.

For this study, records for more than 84,600 patients aged 18 or older from 374 hospitals were included, adjusting for myriad factors, Girotra said, including age, sex, race and the presence of other conditions. Patients were excluded if their cardiac arrests occurred in operating rooms, procedural suites, labor and delivery, or emergency departments.

The study authors estimate that given the improved rate of survival they found, an additional 17,200 patients survived to hospital discharge in 2009 as compared with 2000. The rate of surviving the resuscitation attempt but not surviving the hospital stay was about 54 percent, up from nearly 43 percent in 2000.

Another research team examined information on Medicare patients who had CPR after in-hospital cardiac arrest from 1992 through 2005 and found no difference in survival rates to discharge. Girotra said those results, published in the New England Journal of Medicine in 2009, were likely affected by the fact that the researchers used data from administrative claims that may have included patients who hadn't had cardiac arrests or excluded those without the proper billing procedure code.

Sacco hopes researchers will now evaluate how to improve the outcomes of cardiac arrests that occur in public places. "Improving resuscitation after cardiac arrest is one of the big goals of the AHA," he said.

Girotra said this study is "a small step in trying to understand survival." He added that research is needed to better define what factors have the greatest impact on survival by actually visiting facilities and conducting in-depth interviews.

"When there's a cardiac arrest, somebody's really trying to die right in front of you," said Girotra. "Effective resuscitation really involves a team to perform steps in a coordinated fashion, and these factors differ by hospital. We need to identify what are some of these factors that will help us understand how resuscitation care is organized and what will improve quality so we can better educate physicians and staff."

More information: Learn about the "Get with the Guidelines - Resuscitation" program at the American Heart Association.

Full Text (subscription or payment may be required)

Journal reference: New England Journal of Medicine search and more info website

Copyright © 2012 HealthDay. All rights reserved.

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 2 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 4 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 4 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 4 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created 20 hours ago | popularity 5 / 5 (1) | comments 0


Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...

Research offers promising new approach to treatment of lung cancer

Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage ...

Researchers analyse hunting behaviour of fish larvae in virtual reality

Moving objects attract greater attention – a fact exploited by video screens in public spaces and animated advertising banners on the Internet. For most animal species, moving objects also play a major ...

Overeating learned in infancy, study suggests

In the long run, encouraging a baby to finish the last ounce in their bottle might be doing more harm than good.

Research shows how immune system peacefully co-exists with 'good' bacteria

The human gut is loaded with commensal bacteria – "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the ...

Study details genes that control whether tumors adapt or die when faced with p53 activating drugs

When turned on, the gene p53 turns off cancer. However, when existing drugs boost p53, only a few tumors die – the rest resist the challenge. A study published in the journal Cell Reports shows how: tumors that live even i ...